Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3761868010 | Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3761869019 | Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Is a | Lamivudine and nevirapine and stavudine only product in oral dose form | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has BoSS | Stavudine | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength numerator value | 40 | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has precise active ingredient | Stavudine | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has BoSS | Lamivudine | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has precise active ingredient | Lamivudine | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has BoSS | Nevirapine | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has precise active ingredient | Nevirapine | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Is a | Lamivudine- and nevirapine- and stavudine-containing product | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has active ingredient | Stavudine | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has active ingredient | Lamivudine | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has active ingredient | Nevirapine | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Is a | Lamivudine- and nevirapine- and stavudine-containing product in oral dose form | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and stavudine 40 mg oral tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets